Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Brain Communications|June 19, 2024
Statin use and risk of Parkinson's disease among older adults in Japan: a nested case-control study using the Longevity Improvement and Fair Evidence studySanyu Ge, Ling Zha, Yasuyoshi Kimura, et al.
International Journal of Hematology|July 19, 2023
Efficacy of letermovir in HLA-haploidentical hematopoietic transplantation with posttransplant cyclophosphamideDaishi Nakagawa, Yoshimitsu Shimomura, Satoshi Mitsuyuki, et al.
Critical Care (London, England)|September 30, 2023
Time definition of reintubation most relevant to patient outcomes in critically ill patients: a multicenter cohort studyAiko Tanaka, Yoshimitsu Shimomura, Akinori Uchiyama, et al.
Biological & Pharmaceutical Bulletin|August 18, 2020
Risk Factors for Skin Toxicities Associated with Bendamustine-Based Chemotherapy in Patients with Non-Hodgkin LymphomaMayako Uchida, Yasuhiro Mori, Kenta Akiba, et al.
Clinical Parkinsonism & Related Disorders|August 12, 2025
Functional outcomes in older patients after Parkinson's disease diagnosis in Japan: The LIFE studyMasayo Komatsu, Sanyu Ge, Yasuyoshi Kimura, et al.
Age and Ageing|July 18, 2024
Postdischarge functional outcomes in older patients with acute heart failure in Japan: the Longevity Improvement & Fair Evidence studyNobuhiro Narii, Tetsuhisa Kitamura, Atsushi Hirayama, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2020
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Nationwide Study of the Japan Society for Hematopoietic Cell TransplantationShuhei Kurosawa, Yoshimitsu Shimomura, Takayoshi Tachibana, et al.
Transplantation and Cellular Therapy|February 8, 2024
Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity ConditioningShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Hematological Oncology|October 30, 2018
Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysisTakaaki Konuma, Yoshimitsu Shimomura, Yukiyasu Ozawa, et al.
Bone Marrow Transplantation|March 4, 2021
Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignanciesYoshimitsu Shimomura, Masahiko Hara, Hisashi Yamamoto, et al.
Pageof 10